198 related articles for article (PubMed ID: 10912438)
21. Hormone replacement therapy and risk of colon and rectal cancer.
Fernandez E; La Vecchia C; Braga C; Talamini R; Negri E; Parazzini F; Franceschi S
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):329-33. PubMed ID: 9568789
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
23. Estrogen replacement therapy and colorectal cancer risk in elderly women.
Paganini-Hill A
Dis Colon Rectum; 1999 Oct; 42(10):1300-5. PubMed ID: 10528768
[TBL] [Abstract][Full Text] [Related]
24. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
Lindblad BE; Håkansson N; Philipson B; Wolk A
Ophthalmology; 2010 Mar; 117(3):424-30. PubMed ID: 20045566
[TBL] [Abstract][Full Text] [Related]
25. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
26. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
Keum N; Greenwood DC; Lee DH; Kim R; Aune D; Ju W; Hu FB; Giovannucci EL
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25757865
[TBL] [Abstract][Full Text] [Related]
27. Hormone replacement therapy and lung cancer risk: a case-control analysis.
Schabath MB; Wu X; Vassilopoulou-Sellin R; Vaporciyan AA; Spitz MR
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):113-23. PubMed ID: 14734459
[TBL] [Abstract][Full Text] [Related]
28. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy and endometrial cancer risk: a meta-analysis.
Grady D; Gebretsadik T; Kerlikowske K; Ernster V; Petitti D
Obstet Gynecol; 1995 Feb; 85(2):304-13. PubMed ID: 7824251
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer in women: hormone replacement therapy and chemoprevention.
Barnes EL; Long MD
Climacteric; 2012 Jun; 15(3):250-5. PubMed ID: 22612611
[TBL] [Abstract][Full Text] [Related]
31. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
[TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany.
Hoffmeister M; Raum E; Winter J; Chang-Claude J; Brenner H
Br J Cancer; 2007 Dec; 97(11):1486-92. PubMed ID: 17987040
[TBL] [Abstract][Full Text] [Related]
34. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer and HRT--what are the data?
Bieber EJ; Barnes RB
Int J Fertil Womens Med; 2001; 46(2):73-8. PubMed ID: 11374658
[TBL] [Abstract][Full Text] [Related]
36. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women.
Calle EE; Miracle-McMahill HL; Thun MJ; Heath CW
J Natl Cancer Inst; 1995 Apr; 87(7):517-23. PubMed ID: 7707438
[TBL] [Abstract][Full Text] [Related]
37. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
38. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies.
Yu X; Zhou S; Wang J; Zhang Q; Hou J; Zhu L; He Y; Zhao J; Zhong S
Breast Cancer; 2017 Sep; 24(5):643-657. PubMed ID: 28601917
[TBL] [Abstract][Full Text] [Related]
40. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease.
Humphrey LL; Chan BK; Sox HC
Ann Intern Med; 2002 Aug; 137(4):273-84. PubMed ID: 12186518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]